Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label single-arm study of abexinostat in relapsed or refractory follicular lymphoma
CTR20191596Phase 2Active
- Sponsor
- PPD Pharmaceutical Development (Beijing)
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abexinostat in follicular lymphoma (FL), sponsored by PPD Pharmaceutical Development (Beijing). Started Jun 2020; status: active.
02
Drugs
abexinostat
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on CTR20191596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191596.